Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Dist Recall
Ongoing
Drugs
Class II — Moderate
Recall Date
Jul 29, 2026
Company
Major Pharmaceuticals
Source
FDA
Units
N/A
Reason: Subpotent Drug
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Recall Details
Description
Subpotent Drug
Reason for Recall
Subpotent Drug
What Should I Do?
Quantity: N/A
Remediation GuideAction Required
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
1
Confirm Your Product Is Affected2
Read the Full Recall Notice3
Stop Using the Product if in Doubt+2 more steps…
Last updated August 4, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.